Meridian bioscience inc (VIVO)
CashFlow / Quarterly
Mar'20Dec'19Sep'19Jun'19Mar'19Dec'18Sep'18Jun'18Mar'18Dec'17Sep'17Jun'17Mar'17Dec'16Sep'16Jun'16Mar'16Dec'15Sep'15Jun'15Mar'15Dec'14Sep'14Jun'14Mar'14Dec'13Sep'13Jun'13Mar'13Dec'12Sep'12Jun'12Mar'12Dec'11Sep'11Jun'11Mar'11Dec'10Sep'10Jun'10Mar'10Dec'09
CASH FLOWS FROM OPERATING ACTIVITIES
Net earnings

9,359

2,827

4,103

5,079

7,094

8,106

5,434

6,825

5,288

6,302

5,726

240

9,312

6,279

5,491

8,754

9,091

8,893

8,467

9,102

10,070

7,901

8,182

8,835

10,300

7,426

9,150

10,159

10,249

8,474

8,573

8,594

9,626

6,578

6,710

6,836

7,260

6,025

5,322

6,424

5,980

8,921

Non-cash items included in net earnings:
Depreciation of property, plant and equipment

1,221

1,218

1,449

1,422

1,309

1,253

1,171

1,084

1,090

1,146

1,087

1,101

1,076

1,078

1,066

1,086

889

896

885

753

905

927

889

878

868

888

832

856

851

815

830

900

857

903

855

814

866

845

797

777

768

762

Amortization of intangible assets

1,727

1,722

1,753

1,120

829

829

701

849

945

938

933

939

936

968

856

1,072

374

388

439

409

431

469

490

507

516

526

554

550

585

580

557

545

543

520

525

595

606

595

502

345

339

395

Amortization of deferred instrument costs

-

-

-

-

-

-

183

180

200

201

227

245

243

257

262

285

263

281

303

334

359

395

421

417

426

438

398

385

365

381

355

240

198

149

-

-

-

-

-

-

-

-

Stock-based compensation

971

788

523

360

698

1,670

520

907

216

1,759

490

531

476

1,884

257

364

679

1,611

648

722

526

1,428

895

505

506

1,651

518

411

427

1,146

317

349

342

979

523

657

357

967

611

334

362

559

Deferred income taxes

237

419

35

-175

-773

96

-229

1,505

48

-1,624

464

-972

-109

2,091

520

-447

-739

433

148

-13

-357

100

298

-407

-324

293

-467

-1,078

-142

-136

43

-645

-167

-679

404

-302

-365

-955

120

1,027

-704

-431

Change in accrued contingent consideration

-2,491

1,187

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Losses on dispositions of long-lived assets

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

-20

-1

-9

-156

-212

-14

23

-439

-1

-2

-4

-11

-2

-13

0

Change in the following:
Accounts receivable

5,500

-550

3,328

-1,965

1,268

-317

4,395

-4,133

1,196

2,989

923

-10

2,489

-2,191

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Inventories

-1,015

3,526

-3,908

899

-869

37

-2,976

1,748

17

2,353

432

-1,651

-2,417

169

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Prepaid expenses and other current assets

156

-1,434

195

2,135

253

-539

-2,429

2,860

-667

-87

928

531

-3,090

406

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Accounts payable and accrued expenses

2,285

-664

-612

-436

2,814

-4,081

1,157

-779

2,431

1,315

2,417

-2,153

-2,502

-913

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Income taxes payable

864

-464

391

294

117

991

479

-228

-1,272

497

-403

-127

102

44

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Change in current assets, net of acquisition

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

2,651

5,719

1,186

1,680

-2,511

11,788

-4,878

-5,276

148

8,256

-1,600

361

3,602

4,754

-5,231

-1,620

1,495

-3,827

2,718

20,938

-3,048

-9,404

2,276

278

-793

-3,250

6,194

Change in current liabilities, net of acquisition

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-637

671

834

2,442

-2,572

3,122

246

-1,941

-912

291

-3,434

1,718

2,067

-1,266

150

5,690

-1,445

423

-1,452

1,881

-142

868

-3,177

1,448

474

571

3,282

Other, net

-895

203

954

-480

-129

197

-775

125

-268

108

-206

203

413

311

43

283

-201

58

94

120

-678

259

-157

-358

116

43

420

-366

-17

603

1,863

112

795

100

102

-526

1,737

-665

151

566

-523

-37

Unrealized loss on auction-rate securities and rights, net

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

2

3

-15

Net cash provided by operating activities

10,427

5,288

7,485

7,295

11,565

9,486

11,201

9,743

8,668

5,171

8,864

7,359

12,139

12,993

11,219

7,543

6,369

12,092

11,613

11,165

3,946

16,085

14,651

10,055

4,211

9,345

11,922

10,134

6,333

16,047

10,558

13,023

6,368

12,497

5,838

6,277

-3,258

13,599

6,032

7,074

3,457

13,170

CASH FLOWS FROM INVESTING ACTIVITIES
Purchase of property, plant and equipment

1,203

340

483

1,201

1,004

1,109

861

1,180

926

1,234

1,065

1,129

881

1,392

1,316

1,164

748

776

830

1,222

1,230

1,331

1,338

1,395

1,674

899

1,041

785

1,005

403

545

1,138

795

1,052

1,473

2,406

2,701

2,559

-598

1,557

1,244

880

Purchase of equity method investment

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

600

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Proceeds from sale of assets

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

400

-

-

-

-

-

-

-

-

Purchase of intangibles and other assets

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

16

-

-

-

-

9

10

39

1,638

-

-

-

-

0

0

15

1,290

0

0

0

12

-

-

0

0

Purchases of short-term investments

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

1,000

Net cash used for investing activities

-1,203

-340

101

-46,440

-1,004

-1,109

-861

-1,180

-926

-1,234

-1,065

-1,129

-881

-1,392

-1,317

-1,061

-62,925

-1,392

-981

-84

-1,230

-1,331

-1,347

-1,405

-1,713

-2,537

-1,064

-785

-1,025

-403

-545

-1,138

-810

-1,942

-1,473

-2,406

-2,701

-2,571

-19,926

6,718

-1,244

-1,880

CASH FLOWS FROM FINANCING ACTIVITIES
Dividends paid

-

-

0

0

5,311

5,301

5,300

5,293

5,289

5,288

5,276

5,275

5,275

8,440

8,416

8,416

8,410

8,407

8,343

8,343

8,341

8,330

8,298

8,295

8,294

7,875

7,854

7,848

0

15,652

7,809

7,808

7,806

7,803

7,751

7,741

7,731

7,720

7,703

7,702

7,695

6,885

Payments on term loan

-

-

0

48,000

1,125

1,125

1,125

1,125

1,125

1,125

1,125

1,125

750

750

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Proceeds from exercise of stock options

-

-

-

-

377

66

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Proceeds and tax benefits from exercises of stock options

-

-

-

-

-

-

-

-

-

-

0

0

2

301

461

64

499

1,470

1,960

0

155

499

380

89

133

407

658

39

665

1,390

153

143

-13

269

1,942

652

90

739

236

37

426

96

Net cash used for financing activities

-

-

173

27,506

-6,059

-6,360

-8,531

-6,235

-6,414

-6,413

-6,401

-6,400

-6,023

-8,889

-8,696

-9,093

51,931

-6,937

-6,383

-8,343

-8,186

-7,831

-7,918

-8,206

-8,161

-7,468

-7,196

-7,809

665

-14,262

-7,656

-7,665

-7,819

-7,534

-5,809

-7,089

-7,641

-6,981

-7,467

-7,665

-7,269

-6,789

Effect of Exchange Rate Changes on Cash and Equivalents and Restricted Cash

-1,115

1,212

-554

-266

72

-257

24

-798

361

115

421

678

234

-662

217

-532

149

-314

-251

518

-1,327

-454

-1,624

628

147

107

257

229

-528

174

1,298

-619

393

-442

-493

402

500

-447

1,021

-702

-610

-71

Net Increase (Decrease) in Cash and Equivalents and Restricted Cash

-19,007

6,160

7,205

-11,905

4,574

1,760

1,833

1,530

1,689

-2,361

1,819

508

5,469

2,050

1,423

-3,143

-4,476

3,449

3,998

3,256

-6,797

6,469

3,762

1,072

-5,516

-553

3,919

1,769

5,445

1,556

3,655

3,601

-1,868

2,579

-1,937

-2,816

-13,100

3,600

-20,340

5,425

-5,666

4,430